BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 844227)

  • 1. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF; McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
    Strife CF; Jackson EC; McAdams AJ
    Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F; Leyva-Cobián F; Martínez-Montero JC; Gonzalo A; Bellas C; Moneo I; Junquera E
    Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granular dense deposit disease.
    King JT; Valenzuela R; McCormack LJ; Osborne DG
    Lab Invest; 1978 Dec; 39(6):591-6. PubMed ID: 368430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Membranoproliferative glomerulonephritis. Morphological observations and considerations on pathogenesis].
    Anders D
    Immun Infekt; 1982 Nov; 10(6):219-29. PubMed ID: 6764212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and resolution of glomerular basement membrane changes associated with subepithelial immune deposits.
    Törnroth T; Skrifvars B
    Am J Pathol; 1975 May; 79(2):219-36. PubMed ID: 1096633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF; McAdams AJ; West CD
    Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular complement components in human glomerulonephritis.
    Verroust PJ; Wilson CB; Cooper NR; Edgington TS; Dixon FJ
    J Clin Invest; 1974 Jan; 53(1):77-84. PubMed ID: 4586873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
    Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
    Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basement membrane-changes in membranoproliferative glomerulonephritis: a light and electron microscopic study.
    Anders D; Thoenes W
    Virchows Arch A Pathol Anat Histol; 1975 Dec; 369(2):87-109. PubMed ID: 56082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry of glomerulonephritis.
    Berger J; Yaneva H; Hinglais N
    Adv Nephrol Necker Hosp; 1971; 1():11-30. PubMed ID: 5006252
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the evolution of idiopathic rapidly progressive glomerulonephritis.
    Davis CA; McEnery PT; Maby S; McAdams AJ; West CD
    Clin Nephrol; 1978 Mar; 9(3):91-101. PubMed ID: 346274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and approaches to therapy of membranoproliferative glomerulonephritis.
    West CD
    Kidney Int; 1976 Jan; 9(1):1-7. PubMed ID: 133266
    [No Abstract]   [Full Text] [Related]  

  • 18. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM; Vallota EH; West CD
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological, ultrastructural and immunofluorescence studies in membranoproliferative glomerulonephritis.
    Nagi AH
    J Pathol; 1972 Mar; 106(3):151-4. PubMed ID: 4114030
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type I MPGN).
    Levy M; Gubler MC; Sich M; Beziau A; Habib R
    Clin Immunol Immunopathol; 1978 Aug; 10(4):477-92. PubMed ID: 357058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.